Alloy Therapeutics

investment firm

About

Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.

Details

Last Funding Type
Series C
Last Funding Money Raised
$75M
Industries
Biopharma,Biotechnology,Life Science,Therapeutics
Founded date
Jan 1, 2017
Operating Status
Active

Alloy Therapeutics makes medicine by democratizing access to foundational drug discovery platforms and services. Alloy-Gx, its first platform, is a royalty-free suite of immunocompetent transgenic mice enabling best-in-class in vivo human antibody discovery.

Founded in 2017, Alloy Therapeutics is headquartered in Waltham, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$128.25M
Alloy Therapeutics has raised a total of $128.25M in funding over 2 rounds. Their latest funding was raised on Oct 3, 2022 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 3, 2022 Series D $42M 5 8VC
Mubadala Capital Ventures
Detail
Apr 2, 2021 Series C $75M 10 8VC
Peter Thiel
Presight Capital
Detail
Jun 5, 2020 Series B $11.25M 2 8VC Detail

Investments

Number of Investments
Number of Lead Investments
6
5
Alloy Therapeutics has made 6 investments. Their most recent investment was on Jun 2, 2022, when Vernal Biosciences raised $21M.
Date Company Name
Round Money Raised Industry Lead Investor
Series Unknown $21M Biotechnology
Corporate Round Biotechnology Yes
Series A $7M Biotechnology Yes
Jan 4, 2022 Wheeler Bio
Seed $14M Biotechnology Yes
Jul 21, 2021 Wheeler Bio
Funding Round Biotechnology Yes

Investors

Number of Lead Investors
Number of Investors
6
11
Alloy Therapeutics is funded by 11 investors. 8VC and Mubadala Capital Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
8VC Yes Series D
Mubadala Capital Ventures Yes Series D
Peter Thiel Yes Series C
Founders Fund Series D
Presight Capital Series D
Thiel Capital Series D
Gaingels Series C
Alexandria Venture Investments Series C
Bossanova Investimentos Series C
Luma Bio-IT Series C

Employee Profiles

Number of Employee Profiles
7
Alloy Therapeutics has 7 current employee profiles, including Board member Fabian Hansen
Board member
Executive
Board member
Board member
Executive

Acquisition

Alloy Therapeutics has acquired 1 organizations. Their most recent acquisition was deepCDR Biologics on Dec 9, 2021. They acquired deepCDR Biologics for 0.

Date Company Name
Industry Acquisition Type Price
Biotechnology acquisition Detail